  In this issue of Cancer Cell , McBride and colleagues report that the synovial sarcoma<disease> SS18-SSX fusion drives BAF complex recruitment to bivalent domains repressed by PRC2 complex to orchestrate aberrant transcriptional activation. Redistribution of BAF localization is a major driver of synovial sarcoma<disease> proliferation and presents a promising therapeutic target.